| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 33 |
| 1 | PREDNISOLONE | 31 |
| 2 | PREDNISOLONE ORAL | 31 |
| 3 | PREDNISOLONE ORAL SOLUTION | 31 |
| 4 | TACROLIMUS | 25 |
| 5 | BEVACIZUMAB | 23 |
| 6 | INFLIXIMAB | 22 |
| 7 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 22 |
| 8 | TACROLIMUS OINTMENT 0.1% | 22 |
| 9 | ADALIMUMAB | 20 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | 3% SODIUM CHLORIDE | 1 | 0.0088 |
| 1 | DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM | 3 | 0.0080 |
| 2 | BEVACIZUMAB-MALY | 1 | 0.0050 |
| 3 | BENZOCAINE AND DEXTROMETHORPHAN HYDROBROMIDE | 1 | 0.0040 |
| 4 | BENZOCAINE AND MENTHOL | 1 | 0.0038 |
| 5 | ETHIODIZED OIL | 2 | 0.0015 |
| 6 | CETYLPYRIDINIUM CHLORIDE | 1 | 0.0015 |
| 7 | DIAZOXIDE | 1 | 0.0014 |
| 8 | CASPOFUNGIN ACETATE | 2 | 0.0013 |
| 9 | TAFASITAMAB-CXIX | 1 | 0.0011 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 17 | 0.0008 |
| 1 | Interleukin-17 Receptor A Antagonist [EPC] | 1 | 0.0005 |
| 2 | Antihypoglycemic Agent [EPC] | 2 | 0.0005 |
| 3 | Tyrosine Kinase 2 Inhibitor [EPC] | 1 | 0.0003 |
| 4 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 2 | 0.0002 |
| 5 | Progestin Antagonist [EPC] | 1 | 0.0002 |
| 6 | Provitamin D2 Compound [EPC] | 6 | 0.0002 |
| 7 | SLAMF7-directed Immunostimulatory Antibody [EPC] | 1 | 0.0002 |
| 8 | Sulfone [EPC] | 2 | 0.0002 |
| 9 | CD38-directed Cytolytic Antibody [EPC] | 1 | 0.0002 |